Choate Investment Advisors Grows Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Choate Investment Advisors increased its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 14.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 3,714 shares of the company’s stock after buying an additional 472 shares during the period. Choate Investment Advisors’ holdings in GE HealthCare Technologies were worth $290,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Natixis Advisors LLC increased its stake in GE HealthCare Technologies by 1.9% during the 4th quarter. Natixis Advisors LLC now owns 387,400 shares of the company’s stock worth $30,288,000 after buying an additional 7,329 shares during the period. Frank Rimerman Advisors LLC increased its stake in GE HealthCare Technologies by 8.2% during the 4th quarter. Frank Rimerman Advisors LLC now owns 3,490 shares of the company’s stock worth $273,000 after buying an additional 265 shares during the period. Intact Investment Management Inc. increased its stake in GE HealthCare Technologies by 15.4% during the 4th quarter. Intact Investment Management Inc. now owns 900 shares of the company’s stock worth $70,000 after buying an additional 120 shares during the period. Atala Financial Inc purchased a new stake in GE HealthCare Technologies during the 4th quarter worth $1,693,000. Finally, Commonwealth Equity Services LLC increased its stake in GE HealthCare Technologies by 49.7% during the 4th quarter. Commonwealth Equity Services LLC now owns 245,476 shares of the company’s stock worth $19,191,000 after buying an additional 81,552 shares during the period. Hedge funds and other institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Trading Up 0.6 %

NASDAQ GEHC opened at $82.47 on Tuesday. GE HealthCare Technologies Inc. has a one year low of $74.51 and a one year high of $94.80. The company has a 50-day simple moving average of $87.27 and a 200-day simple moving average of $86.12. The company has a debt-to-equity ratio of 0.88, a quick ratio of 0.83 and a current ratio of 1.04. The firm has a market capitalization of $37.71 billion, a PE ratio of 19.05, a price-to-earnings-growth ratio of 3.19 and a beta of 1.13.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its earnings results on Thursday, February 13th. The company reported $1.45 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.26 by $0.19. The firm had revenue of $5.32 billion during the quarter, compared to analyst estimates of $5.33 billion. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. On average, equities analysts forecast that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

Wall Street Analyst Weigh In

GEHC has been the subject of several research analyst reports. Wells Fargo & Company boosted their target price on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a research report on Friday, February 14th. Jefferies Financial Group raised shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and boosted their target price for the stock from $95.00 to $103.00 in a research report on Wednesday, January 8th. The Goldman Sachs Group raised shares of GE HealthCare Technologies from a “neutral” rating to a “buy” rating and boosted their target price for the stock from $85.00 to $100.00 in a research report on Tuesday, March 11th. Finally, Citigroup boosted their target price on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a “buy” rating in a research report on Thursday, February 13th. One research analyst has rated the stock with a sell rating, two have issued a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $98.75.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.